In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART)
Open Access
- 22 April 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 55 (6), 965-973
- https://doi.org/10.1093/jac/dki117
Abstract
Objectives: The SMART (Study for Monitoring Antimicrobial Resistance Trends) surveillance programme was begun in 2002 to monitor antimicrobial resistance trends among aerobic and facultative Gram-negative bacilli (GNB) isolated from intra-abdominal infections worldwide. Methods: In 2003, 74 medical centres from 23 countries collected isolates for testing. Antimicrobial susceptibility testing was performed using broth microdilution according to the NCCLS guidelines for MIC testing. Results: A total of 5658 aerobic and facultative GNB were isolated from intra-abdominal infections. Enterobacteriaceae composed 84% of the total isolates. Among the agents tested, the carbapenems were the most consistently active against the Enterobacteriaceae. E. coli was the most common isolate (46%), and the susceptibility rate to the quinolone (70–90% susceptible), cephalosporin (80–97% susceptible), aminoglycoside (77–100% susceptible) and carbapenem (99–100% susceptible) agents tested varied among geographic regions, with isolates from the Asia/Pacific region generally being the most resistant. Extended-spectrum beta-lactamases (ESBLs) were detected phenotypically in 9% of E. coli, 14% of Klebsiella spp., and 14% of Enterobacter spp. worldwide. ESBL producers generally had a more antibiotic-resistant profile than non-ESBL producers. Conclusions: Antimicrobial resistance among GNB isolated from intra-abdominal infections is a problem worldwide, especially in the Asia/Pacific region. The carbapenems ertapenem, meropenem and imipenem are highly active in vitro against Enterobacteriaceae isolated from intra-abdominal sites, including organisms that produce ESBLs.This publication has 20 references indexed in Scilit:
- European recommendations for antimicrobial resistance surveillanceClinical Microbiology & Infection, 2004
- Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy, and infection controlJournal of Infection, 2003
- Guidelines for the Selection of Anti-infective Agents for Complicated Intra-abdominal InfectionsClinical Infectious Diseases, 2003
- The need for antimicrobial resistance surveillanceJournal of Antimicrobial Chemotherapy, 2002
- The Surgical Infection Society Guidelines on Antimicrobial Therapy for Intra-Abdominal Infections: An Executive SummarySurgical Infections, 2002
- Determining the value of antimicrobial surveillance programsDiagnostic Microbiology and Infectious Disease, 2001
- Controversies about Extended-Spectrum and AmpC Beta-LactamasesEmerging Infectious Diseases, 2001
- The MYSTIC (meropenem yearly susceptibility test information collection) programmeInternational Journal of Antimicrobial Agents, 1999
- Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)Antimicrobial Agents and Chemotherapy, 1998
- A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: The Alexander ProjectJournal of Antimicrobial Chemotherapy, 1996